| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/10/2010 | EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1411932B1 Substituted oxazolidinones for combinational therapy |
| 02/10/2010 | CN101643471A C3/C3 fluoroquinolone dimmer derivative using oxadiazole as connection chain as well as preparation method and application thereof |
| 02/09/2010 | US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2010 | US7659394 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 02/09/2010 | US7659314 PH-sensitive polymeric micelles for drug delivery |
| 02/09/2010 | US7659298 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 02/09/2010 | US7659294 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists |
| 02/09/2010 | US7659280 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | US7659268 Modulators of ATP-binding cassette transporters |
| 02/09/2010 | US7659265 5-(4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; menopause therapy; contraceptive; anticancer agents |
| 02/09/2010 | CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/09/2010 | CA2268403C Anthranilic acid derivatives as multi drug resistance modulators |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | WO2010013161A1 Fluorinated heteroaryls |
| 02/04/2010 | WO2010013037A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 02/04/2010 | WO2010012740A1 5-alkynyl-pyrimidines |
| 02/04/2010 | WO2010012620A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | WO2010012619A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | WO2010012121A1 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia |
| 02/04/2010 | WO2010012107A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 02/04/2010 | WO2009126003A3 Novel pyrazole and benzoxazole-substituted pyridine derivatives or pharmaceutically acceptable salts thereof, preparation process for same, and pharmaceutical composition for prevention and treatment of disorders involving aberrant cell proliferation containing same as active ingredients |
| 02/04/2010 | US20100029950 Novel substituted 1h-dihydropyrazoles, their preparation and use |
| 02/04/2010 | US20100029949 Activator for Peroxisome Proliferator Activated Receptor |
| 02/04/2010 | US20100029938 Process for the preparation of an antibacterial quinolone compound |
| 02/04/2010 | US20100029754 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 02/04/2010 | US20100029729 Compounds |
| 02/04/2010 | US20100029728 Phosphodiesterase inhibitors |
| 02/04/2010 | US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists |
| 02/04/2010 | US20100029687 Piperidine derivative or salt thereof |
| 02/04/2010 | US20100029685 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 02/04/2010 | US20100029682 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 02/04/2010 | US20100029664 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | US20100029653 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
| 02/04/2010 | US20100029650 Bicyclic compounds and use as antidiabetics |
| 02/04/2010 | US20100029649 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 02/04/2010 | US20100029647 3,4,(5)-substituted tetrahydrophyridines |
| 02/04/2010 | US20100029646 Prodrugs of diphenyl ox-indol-2-one compounds |
| 02/04/2010 | US20100029645 Inhibitors of Cytosolic Phospholipase A2 |
| 02/04/2010 | US20100029644 Compounds Which Modulate The CB2 Receptor |
| 02/04/2010 | US20100029643 Heterocyclyc sulfonamides having edg-1 antagonistic activity |
| 02/04/2010 | US20100029640 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| 02/04/2010 | US20100029638 Fused heterocyclyc inhibitor compounds |
| 02/04/2010 | US20100029636 Lck inhibitors |
| 02/04/2010 | US20100029635 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents |
| 02/04/2010 | US20100029632 improved pharmacokinetics |
| 02/04/2010 | US20100029628 2,4,5-Substituted Piperidines as Renin Inhibitors |
| 02/04/2010 | US20100029620 Substituted triazoline, tetrazolone and imidazolone derivatives for use as a medicine |
| 02/04/2010 | US20100029615 Benzimidazole derivatives |
| 02/04/2010 | US20100029610 Heteroaryl Compounds and Uses Thereof |
| 02/04/2010 | US20100029606 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/04/2010 | US20100029605 Compounds and compositions as protein kinase inhibitors |
| 02/04/2010 | US20100029592 Deuterium-enriched fosaprepitant |
| 02/04/2010 | US20100029589 4,5-dihydro-oxazol-2yl derivatives |
| 02/04/2010 | CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | CA2732336A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | CA2731909A1 5-alkynyl-pyrimidines |
| 02/04/2010 | CA2731873A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 02/04/2010 | CA2731403A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | CA2729581A1 Fluorinated heteroaryls |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149550A1 Nitrogen-containing five-membered heterocyclic compound |
| 02/03/2010 | EP2148878A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/03/2010 | EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148692A2 Melanocortin receptor ligands modified with hydantoin |
| 02/03/2010 | EP2148677A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | US7655808 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/02/2010 | US7655798 crystallizing aripiprazole Type II from a solution of aripiprazole dissolved in a solvent selected from 2-propanol, dimethylsulfoxide or mixture and optionally further comprising ethyl acetate; solid state Type II aripiprazole without the use of a solid state heat treatment |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655679 Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655650 Oxadiazine derivatives |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | US7655645 Indole derivatives |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | CA2516682C Imidazol-4-yl-ethynyl-pyridine derivatives |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |